John Overington

Minimum information about a bioactive entity (MIABE)

Peter Murray-Rust, John P. Overington, Henning Hermjakob, 2011, Nature Reviews Drug Discovery.

Drug discovery and development in the era of Big Data.

Jürgen Bajorath, Jeremy L Jenkins, John Overington, 2016, Future medicinal chemistry.

Symposium 1: Structure and engineering of proteins: New developments

Dan Donnelly, John Overington, Hartmut Michel, 1990 .

X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes

John P. Overington, John Overington, Tom Blundell, 1989, Nature.

Probing the links between in vitro potency, ADMET and physicochemical parameters

John P. Overington, Anne Hersey, John Overington, 2011, Nature Reviews Drug Discovery.

Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation.

John P. Overington, Bissan Al-Lazikani, John Overington, 2010, Drug discovery today.

Protein sequence analysis in silico: application of structure-based bioinformatics to genomic initiatives.

John P. Overington, John Overington, R. Fagan, 2002, Current opinion in pharmacology.